LUXCOR health event in Brussels: showing Luxembourg’s way to next-generation healthcare
The first health event, organised by the Luxembourg Contact Office for Research & Innovation in Brussels (LUXCOR) jointly with LIH, was held in Brussels on 19th June 2017. It gathered around 50 participants and was aimed at informing about Luxembourg’s efforts and developments in clinical and translational medicine, Big Data, eHealth and next-generation healthcare.
LUXCOR is a joint venture between the six main Research, Development and Innovation (RDI) stakeholder organisations in Luxembourg: LIH, the Luxembourg Institute of Socio-Economic Research (LISER), the Luxembourg Institute of Science and Technology (LIST), Luxinnovation (national innovation agency), the Luxembourg National Research Fund (FNR) and the University of Luxembourg (UL). The main missions of LUXCOR are to make Luxembourg better known as a centre of research and innovation, to help raise Luxembourg participation in EU RDI programmes, and to develop RDI links with partner organisations elsewhere in Europe.
After an overview of the Luxembourg biomedical and health research ecosystem given by Dr Frank Glod of the FNR, there were two presentations by representatives of the European Commission - by Directorate General for Communications Networks, Content and Technology (DG CNECT) on eHealth and by Directorate General for Research and Innovation (DG RTD) on personalised medicine. The presentations were followed by a round table with the European Commission, LIH, UL, “Agence eSanté Luxembourg” and the Luxembourg-based company ITTM.
LUXCOR could show that Luxembourg is strong in IT, infrastructure and data security and is therefore well positioned to develop into a data hub for biomedical data. Ambitious projects such as the National Centre for Excellence in Research in Parkinson’s Disease and the Centre of Excellence in Digital Health and Personalised Medicine that is currently in the planning phase were highlighted. The European Commission that considers the digital transformation of health and care as a top priority, sees Luxembourg as an ideal testbed for eHealth and personalised medicine. During the round table emphasis was put on cybersecurity and trust as well as on efficient cooperation with other European countries.
LIH was represented at the event by Dr Catherine Larue, CEO ad interim of LIH; Marc Vandelaer, CEO ad interim of IBBL - Integrated Biobank of Luxembourg; Dr Anna Chioti, Director ad interim of LIH’s Department of Population Health; and Dr Fabrice Mouche, Head of LIH’s Research Knowledge Transfer Office. LUXCOR intends to organise a follow-up health event at the end of 2017 in Brussels, possibly in co-organisation with other Brussels Offices.
View the three presentations presented at the event:
Dr Anna Chioti, Director ad interim of LIH’s Department of Population Health, presenting at the LUXCOR health event in Brussels.
Representatives from Luxembourg at the LUXCOR health event. From left to right: Dr Younis Hijazi (Luxinnovation), Dr Charles Betz (Luxinnovation). Dr Thomas Dentzer (Luxinnovation), Dr Frank Glod (FNR), Dr Catherine Larue (LIH), Dr Fabrice Mouche (LIH) and Marc Vandelaer (IBBL).